Enlivex Therapeutics Ltd (ENLV) — Strategic Asset Allocation Index
Enlivex Therapeutics Ltd (ENLV) has a Strategic Asset Allocation Index of 32.3% as of June 2023. Strategic assets (PP&E of ILA14.31 Million plus long-term investments of ILA-) total ILA14.31 Million, measured against net assets of ILA44.34 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Enlivex Therapeutics Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Enlivex Therapeutics Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Enlivex Therapeutics Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 32.3%, representing strategic assets of ILA14.31 Million against net assets of ILA44.34 Million ILA. See Enlivex Therapeutics Ltd (ENLV) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Enlivex Therapeutics Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Enlivex Therapeutics Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Enlivex Therapeutics Ltd stock valuation.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 26.2% | ILA14.90 Million | ILA14.90 Million | ILA- | ILA56.84 Million | ▲ +23.2 pp |
| 2021 | 3.0% | ILA2.53 Million | ILA2.53 Million | ILA3.00K | ILA85.04 Million | ▼ -3.1 pp |
| 2020 | 6.0% | ILA2.14 Million | ILA2.14 Million | ILA0.00 | ILA35.49 Million | ▼ -3.3 pp |
| 2019 | 9.4% | ILA1.06 Million | ILA1.06 Million | ILA- | ILA11.28 Million | ▲ +2.3 pp |
| 2018 | 7.1% | ILA685.00K | ILA685.00K | ILA- | ILA9.71 Million | ▼ -5.2 pp |
| 2017 | 12.3% | ILA388.00K | ILA388.00K | ILA- | ILA3.16 Million | ▲ +8.7 pp |
| 2016 | 3.6% | ILA314.00K | ILA314.00K | ILA- | ILA8.70 Million | — |